ANOROÂ ELLIPTA is a combination of umeclidinium, an anticholinergic, and. vilanterol, a long-acting beta2-adrenergic agonist (LABA), indicated for the. maintenance treatment of patients with chronic obstructive pulmonary disease. (COPD).
| Anoro Ellipta Brand |
55/22mcg 1 Inhaler |
$126.00 |
ANORO is indicated as a maintenance bronchodilator treatment to relieve symptoms in adult patients with chronic obstructive pulmonary disease (COPD).ANORO ELLIPTA is NOT indicated for the relief of acute bronchospasm or for the treatment of asthma.
Send Your Prescription
No Hidden Fees
Typically Under 7 days
Are you wondering which drugs are most popular on the IsraelPharm website? Maybe you or someone you know is looking for an alternative source for your prescriptions meds? then read on if you’re curious about
Several reports have been published in the past few months saying that the rate of uterine cancer has risen significantly over the past decade in the US. More importantly, the death rate in women diagnosed
It may sound too good to be true. However, there is a lot of advanced research going on to discover whether and how the life expectancy of you and me can be improved. Right now,
Coffee is the natural picker upper. It is the one thing that gets some us through the day, or at least out of bed. Coffee today is so common and seems so harmless that we
I know we always talk about how much money you can save when buying prescriptions online but I just wanted to show you some case studies so you can see for yourself what happens when you
Most of the widespread knowledge about drugs like Viagra, Levitra and Cialis, which are based on variants of PDE-5 inhibitors, is focused on their ability to induce more vigorous and sustained erections in men suffering
In May 2023, the FDA allowed the treatment of heart failure with Farxiga (dapagliflozin), a sodium-glucose cotransporter 2 (SGLT2) inhibitor. The first SGLT2 inhibitor to be FDA-approved was Invokana (canagliflozin) in March 2013, followed by
For many decades there has been an awareness of mood disorders grouped under the title of PMADs, which describe changes that mothers undergo during and immediately after childbirth. Now, the new experiences brought on by
